Abstract  The pharmaceutical industry is one of the most regulated activity sectors. The regulation includes specific quality systems such as good laboratory practice (GLP), good clinical practice (GCP) and good manufacture practice (GMP). The principles of GLP mainly cover the formal quality aspects of a procedure and do not evaluate the technical aspects in depth. On the other hand, EN 45001 accreditation covers technical performance and is not suitable for pharmaceutical research and development (R&D) as it is almost impossible to comply with the requirements of the European standard in the pharmaceutical environment. The challenge to the pharmaceutical industry is, therefore, to develop quality systems, compatible with GLP principles, that not only cover formal quality items but also ensure good scientific and technical performance. An implementation process focused on real quality improvement is the best way to achieve this objective, culminating in formal recognition of the quality system by third-party assessment. In the case of analytical R&D, the EURACHEM/CITAC Guide CG2 is a very good tool that can help in the definition, analysis and selection of the non GLP quality elements that will be useful.
good clinical practice (GCP)1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Good_Clinical_Practice

GLP                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Good_Laboratory_Practice

GLP                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Good_Laboratory_Practice

R&D                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Research_and_development

GMP                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Good_manufacturing_practice

GLP                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Good_Laboratory_Practice

CG2                           0.9967732958676018^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/British_NVC_community_CG2

pharmaceutical industry       0.9984243394265967^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Pharmaceutical_industry

pharmaceutical                0.8129329449828518^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Pharmaceutical_industry

R&D                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Research_and_development

pharmaceutical industry       0.9984243394265967^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Pharmaceutical_industry

GLP                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Good_Laboratory_Practice

pharmaceutical                0.8129329449828518^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Pharmaceutical_industry

good laboratory practice      1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Good_Laboratory_Practice

